Translational imaging services

In vitro and in vivo imaging services are offered for your needs. We also provide multimodality imaging services for various disease models.


Magnetic Resonance Imaging (MRI)

MRI provides a quantitative method of tumor detection and monitoring of disease progression in situ.


Bioluminescence Imaging (BLI)

Through the use of transgenic animals or cells with the luciferase protein, tumor growth can be visualized through the use of a luciferin substrate which results in the emission of light that is captured by a specially-designed camera.






 

 

 

 

 

 

 

 

All services need to be requested through iLab

 

Director

Dr. Hong Zeng, MD, PhD

Contact for genome editing and mouse line services

650-724-9556

hongzeng@stanford.edu

 

Associate Director

Nirk Quispe Calla, MD

Contact for tumor model services

650-721-1485

nirk.quispe@stanford.edu